Over 1000 Total Lots Up For Auction at Two Locations - IL 11/19, NJ Cleansweep 11/21

Evidence grows for statins' cancer-fighting prowess

by Brendon Nafziger, DOTmed News Associate Editor | March 24, 2011
Statins might do more
than lower cholesterol.
Statins appear to boost radiotherapy's prostate cancer cure rate for high-risk patients, according to a new report, as evidence mounts for statins' anti-cancer abilities.

The retrospective study looking at more than 1,000 prostate cancer patients undergoing radiation and hormone therapy found slightly higher survival rates among patients with aggressive cancers who were taking the commonly prescribed cholesterol-busting drug.

In the study, published in this month's issue of the International Journal of Radiation Oncology•Biology•Physics, the researchers looked at the records of 1,681 prostate cancer patients who received high-dose (median 81 Gy) radiotherapy treatments, with slightly more than half also getting hormone therapy, between 1995 and 2007 at Memorial Sloan-Kettering Cancer Center in New York.
stats
DOTmed text ad

Quality, speed, and peace of mind

GE HealthCare’s Repair Center Solutions are an ideal complement to your in-house service team. We service a broad range of mobile devices, including monitors and cardiology devices, parts, and portable ultrasound systems and probes.

stats
About one-fifth of the men (382) were also taking statins. And for those high-risk men consuming the medicine, technically known as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, their drug regimen might have done more than lower their cholesterol levels.

For high-risk patients in the statin group, the five-year and eight-year tumor-control rates based on the prostate-specific antigen blood levels were 81 percent and 75 percent. For high-risk patients not taking the drugs, corresponding tumor-control rates were 68 percent and 58 percent, respectively. No statistically significant difference was found among prostate cancer patients with low- or medium-risk disease. Nor was any benefit seen in distant metastases-free survival.

"In all likelihood, for those patients who have low-risk disease, we don't see the effects of the statins to begin with, because the treatments themselves are very effective in terms of their ability to kill the cancers," senior author Dr. Michael J. Zelefsky, professor of radiation oncology and chief of brachytherapy services at Memorial Sloan-Kettering, told DOTmed News.

Zelefsky's research backs up a growing body of evidence for statins' ability to help prostate cancer patients survive, at least for those undergoing radiation therapy. A retrospective 2010 study of almost 700 men by University of Chicago researchers published in the Journal of Clinical Oncology also found statin use was associated with increased relapse-free survival.

In the current study, the researchers said there was no obvious confounding factor that would have linked statin-taking with another protective effect. "It appears that there is some kind of positive interaction between the statins, possibly the hormonal therapy, and the radiation therapy," Zelefsky said.

But the exact mechanism that could be causing this effect, if it's real, is unclear. Hypotheses for statins' anti-cancer activity cover a wide range. The drugs could kill cancer cells outright by triggering apoptosis or they could enhance the sensitivity of radiation so more cancer cells can be destroyed during treatment.

Whatever the case, it's still too early to start changing clinical practice, as the studies so far have all been retrospective. The researchers don't know, for instance, what the appropriate dose of statins would be, or what type to use. Zelefsky said it's important now to corroborate the findings with prospective, randomized controlled trials. In the meantime, he's continuing to follow up with the patients in the study and looking to work with national groups on getting a large, multicenter trial off the ground.
(1)

Michael Polski

FALSE AND MISLEADING GREED

March 28, 2011 10:03

Don't get it wrong. STATINS have NEVER been shown to increase life span! Despite the studies of these mega billion dollar drugs, they have never increased longevity of life, and for many, have shorted it! Extensive studies have been done on animals in labs, to show that statins DEPLETE Coenzyme Q10! (Remember Leninger's Biochemistry and the Krebs Cycle?) The Kreb's cycle is about the mitochondria making energy (ATP) out of fuel (fats, sugars, and proteins).
The entire chain of reactions, below the circle of the Kreb's cycle depends on CoQ10!. This is suppressed by all statins, and if people do not take a CoQ10 supplement with statins, it stressed the cell, leaving it more suseptible to cancer, and this is why we see an INCREASE IN CANCER in those who take STATINS. (Note the Denmark study on Vytorin). STATINS are way over-hyped. The way to longevity is a plant-based diet, free of alchohol, smoking, and caffeine, as well as other lifestyle factors (sleep, stress, interval exercise...) not STATINS...they don't give longer life...and that's the truth.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment